Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 1,931,758	$ 1,192,230
Trade accounts receivable, less allowance for credit losses (2025 – $4,705; 2024 – $5,201)	733,477	742,201
Other accounts receivable	107,701	238,384
Inventories	1,532,622	1,502,531
Other current assets	249,347	166,916
Total current assets	4,554,905	3,842,262
Property, plant and equipment, at cost	12,902,998	12,523,368
Less accumulated depreciation and amortization	3,680,755	3,191,898
Net property, plant and equipment	9,222,243	9,331,470
Investments	914,040	1,117,739
Other assets	736,279	504,711
Goodwill	1,490,869	1,582,714
Other intangibles, net of amortization	229,949	230,753
Total assets	17,148,285	16,609,649
Current liabilities:
Accrued expenses	500,940	467,997
Current portion of long-term debt	445,384	398,023
Dividends payable	61,339	61,282
Income taxes payable	93,120	95,275
Total current liabilities	2,003,954	1,966,464
Long-term debt	3,181,009	3,118,142
Postretirement benefits	31,915	31,930
Pension benefits	118,004	116,192
Other noncurrent liabilities	1,137,211	819,204
Deferred income taxes	407,134	358,029
Commitments and contingencies (Note 7)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, authorized – 275,000, issued and outstanding – 117,692 in 2025 and 117,560 in 2024	1,177	1,176
Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2025 and 2024	2,235,105	2,235,105
Additional paid-in capital	3,011,210	2,985,606
Accumulated other comprehensive loss	(368,592)	(742,062)
Retained earnings	5,117,213	5,481,692
Total Albemarle Corporation shareholders’ equity	9,996,113	9,961,517
Noncontrolling interests	272,945	238,171
Total equity	10,269,058	10,199,688
Total liabilities and equity	17,148,285	16,609,649
Nonrelated Party
Current liabilities:
Accounts payable	780,377	793,455
Related Party
Current liabilities:
Accounts payable	$ 122,794	$ 150,432